Perrigo | PRGO - Zysk Brutto Na Sprzedaży





Zysk Brutto Na Sprzedaży Zmiana Data
AbbVie USD 12.54B 474M 2026-03
Abbott USD 5.86B 675M 2026-03
Bayer EUR 6.94B 1.58B 2025-12
Bristol-Myers Squibb USD 8.41B 381M 2025-12
Coherus Biosciences USD 8.7M 853K 2025-12
Corcept Therapeutics USD 162.02M 37.56M 2026-03
Dr.Reddys Laboratories INR 37.77B 13.6B 2026-03
Eli Lilly USD 15.92B 1.33B 2025-12
J&J USD 17.24B 642M 2026-03
Merck USD 10.85B 2.57B 2025-12
Nestle CHF 21.43B 174M 2024-12
Pacira USD 126.64M 15.61M 2026-03
Perrigo USD 325.5M 36.7M 2026-03
Pfizer USD 11.04B 1.24B 2026-03
Phibro Animal Health USD 133.5M 12.6M 2025-12
Prestige Brands USD 157.37M 5.79M 2025-12
Reckitt Benckiser GBP 4.25B 2.08B 2024-12
Sanofi EUR 8.45B 1.31B 2025-12
Supernus Pharmaceuticals USD 129.36M 34.68M 2026-03
Teva Pharmaceutical Industries USD 2.11B 547M 2026-03
Xeris Pharmaceuticals USD 72.55M 404K 2026-03
Zoetis USD 1.62B 20M 2026-03